PYC Therapeutics Limited (ASX: PYC)

PYC Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	513	560	191	207	493	337
Market Cap Growth	192.66%	192.66%	-7.47%	-58.06%	46.25%	375.89%
Enterprise Value	448	536	175	165	438	311
Last Close Price	1.10	1.20	0.55	0.64	1.53	1.13
PS Ratio	19.63	25.38	12.10	12.89	160.37	140.72
PB Ratio	6.38	6.91	6.73	5.14	9.14	11.16
P/TBV Ratio	7.32	7.32	8.14	5.92	10.19	14.28
EV/Sales Ratio	20.31	24.29	11.10	10.26	142.63	129.81
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.03
Asset Turnover	0.34	0.34	0.38	0.31	0.07	0.13
Quick Ratio	9.32	9.32	3.79	8.93	15.68	36.15
Current Ratio	9.40	9.40	3.79	8.94	15.71	36.23
Return on Equity (ROE)	-69.61%	-69.61%	-68.05%	-30.37%	-44.29%	-38.80%
Return on Assets (ROA)	-37.83%	-37.83%	-35.49%	-17.29%	-26.20%	-23.88%
Return on Capital (ROIC)	-43.79%	-43.79%	-41.90%	-18.64%	-27.38%	-24.49%
Earnings Yield	-8.73%	-6.74%	-11.91%	-6.70%	-3.60%	-2.02%
FCF Yield	-7.58%	-6.95%	-13.02%	-10.72%	-2.51%	-1.74%
Buyback Yield / Dilution	-22.59%	-22.59%	-0.93%	-2.89%	-12.58%	-17.18%
Total Shareholder Return	-22.59%	-22.59%	-0.93%	-2.89%	-12.58%	-17.18%

Source: S&P Capital IQ. Standard template. Financial Sources.